FDA Import Refusal SCS-3440627-3/11/35 — Astellas Pharma Spa

Astellas Pharma Spa — FEI 3009027462

The FDA refused shipment SCS-3440627-3/11/35 from Astellas Pharma Spa (Italy) on February 21, 2019. The refused product falls under Drugs and Biologics — TAMSULOSIN HCL (REGULATOR). Cited charge: 75 This firm has 5 or more other import refusals on record.

Refusal Details

Date
February 21, 2019
Country
Italy
Product Category
Drugs and Biologics
Product Code
65PCA03 TAMSULOSIN HCL (REGULATOR)
Charges
75